Projects per year
Personal profile
Education
- 中山醫學院醫學系學士
Experience
- 臺南市肝病防治協會理事長
- 成大胃腸肝膽科主治醫師(1995~迄今)
- 成大醫院臨床助理教授(迄今)
- 成大胃腸肝膽科研究員(1993~1995)
- 成大醫院住院醫師(1991~1993)
Research Interests
- 肝臟學 包括各類肝炎
- 肝腫瘤
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Pin-Nan Cheng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
-
-
直接抗病毒藥物治療慢性C型肝炎對脂質、J載脂蛋白、主動脈硬度和心血管疾病風險的長期影響
Cheng, P.-N. (PI)
19-08-01 → 20-07-31
Project: Research project
-
Clinical Relevancies of Sarcopenic Obesity in Patients with Metabolic Dysfunction-Associated Fatty Liver Disease (MASLD)
Chien, S. C., Chiu, H. C., Chiu, Y. C., Wang, R. H., Dillera, K. P. O., Lee, K. T., Tsai, H. W., Tsai, Y. S., Ou, H. Y. & Cheng, P. N., 2025 Mar, In: Digestive Diseases and Sciences. 70, 3, p. 1190-1200 11 p., 100963.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus) -
Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study
TACR investigators, 2025 Jul, In: Clinical and molecular hepatology. 31, 3, p. 899-913 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial
Lim, Y. S., Yu, M. L., Choi, J., Chen, C. Y., Choi, W. M., Kang, W., Kim, G. A., Kim, H. J., Lee, Y. B., Lee, J. H., Park, N. H., Kwon, S. Y., Park, S. Y., Kim, J. H., Choi, G. H., Jang, E. S., Chen, C. H., Hsu, Y. C., Bair, M. J. & Cheng, P. N. & 7 others, , 2025 Apr, In: The Lancet Gastroenterology and Hepatology. 10, 4, p. 295-305 11 p.Research output: Contribution to journal › Article › peer-review
10 Citations (Scopus) -
High-normal and abnormal alanine transaminase levels linked to increased risk of hepatoma following treatment for chronic hepatitis C
TACR investigators, 2025, (Accepted/In press) In: Journal of the Formosan Medical Association.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Impact of HCV eradication by directly acting antivirals on glycemic indices in chronic hepatitis C patients -a nationwide Taiwan HCV registry
Jang, T. Y., Huang, C. F., Chang, T. S., Yang, C. C., Lo, C. C., Hung, C. H., Huang, C. W., Chong, L. W., Cheng, P. N., Yeh, M. L., Peng, C. Y., Cheng, C. Y., Huang, J. F., Bair, M. J., Lin, C. L., Yang, C. C., Wang, S. J., Hsieh, T. Y., Lee, T. H. & Lee, P. L. & 25 others, , 2025 Aug, In: Journal of the Formosan Medical Association. 124, 8, p. 731-737 7 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus)